ACE (I/D) polymorphism and response to treatment in coronary artery disease: a comprehensive database and meta-analysis involving study quality evaluation

go back to reference Arnett DK, Baird AE, Barkley RA, Basson CT, Boerwinkle E, Ganesh SK, Herrington DM, Hong Y, Jaquish C, McDermott DA, O'Donnell CJ, American Heart Association Council on Epidemiology and Prevention; American Heart Association Stroke Council; Functional Genomics and Translational Biology Interdisciplinary Working Group: Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation. 2007, 115: 2878-2901. 10.1161/CIRCULATIONAHA.107.183679.CrossRefPubMed Arnett DK, Baird AE, Barkley RA, Basson CT, Boerwinkle E, Ganesh SK, Herrington DM, Hong Y, Jaquish C, McDermott DA, O'Donnell CJ, American Heart Association Council on Epidemiology and Prevention; American Heart Association Stroke Council; Functional Genomics and Translational Biology Interdisciplinary Working Group: Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation. 2007, 115: 2878-2901. 10.1161/CIRCULATIONAHA.107.183679.CrossRefPubMed

go back to reference Zintzaras E, Kitsios G: Identification of chromosomal regions linked to premature myocardial infarction: a meta-analysis of whole-genome searches. J Hum Genet. 2006, 51: 1015-1021. 10.1007/s10038-006-0053-x.CrossRefPubMed Zintzaras E, Kitsios G: Identification of chromosomal regions linked to premature myocardial infarction: a meta-analysis of whole-genome searches. J Hum Genet. 2006, 51: 1015-1021. 10.1007/s10038-006-0053-x.CrossRefPubMed

go back to reference Damani SB, Topol EJ: Future use of genomics in coronary artery disease. J Am Coll Cardiol. 2007, 50: 1933-1940. 10.1016/j.jacc.2007.07.062.CrossRefPubMed Damani SB, Topol EJ: Future use of genomics in coronary artery disease. J Am Coll Cardiol. 2007, 50: 1933-1940. 10.1016/j.jacc.2007.07.062.CrossRefPubMed

go back to reference Unal B, Critchley JA, Capewell S: Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation. 2004, 109: 1101-1107. 10.1161/01.CIR.0000118498.35499.B2.CrossRefPubMed Unal B, Critchley JA, Capewell S: Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation. 2004, 109: 1101-1107. 10.1161/01.CIR.0000118498.35499.B2.CrossRefPubMed

go back to reference Johnson JA, Cavallari LH: Cardiovascular pharmacogenomics. Exp Physiol. 2005, 90: 283-289. 10.1113/expphysiol.2004.028506.CrossRefPubMed Johnson JA, Cavallari LH: Cardiovascular pharmacogenomics. Exp Physiol. 2005, 90: 283-289. 10.1113/expphysiol.2004.028506.CrossRefPubMed

go back to reference Zintzaras E, Raman G, Kitsios G, Lau J: Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis. Arch Intern Med. 2008, 168: 1077-1089. 10.1001/archinte.168.10.1077.CrossRefPubMed Zintzaras E, Raman G, Kitsios G, Lau J: Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis. Arch Intern Med. 2008, 168: 1077-1089. 10.1001/archinte.168.10.1077.CrossRefPubMed

go back to reference Bonnici F, Keavney B, Collins R, Danesh J: Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: meta-analysis of 16 studies. BMJ. 2002, 325: 517-520. 10.1136/bmj.325.7363.517.CrossRefPubMedPubMedCentral Bonnici F, Keavney B, Collins R, Danesh J: Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: meta-analysis of 16 studies. BMJ. 2002, 325: 517-520. 10.1136/bmj.325.7363.517.CrossRefPubMedPubMedCentral

go back to reference Agema WR, Jukema JW, Zwinderman AH, Wall van der EE: A meta-analysis of the angiotensin-converting enzyme gene polymorphism and restenosis after percutaneous transluminal coronary revascularization: evidence for publication bias. Am Heart J. 2002, 144: 760-768.CrossRefPubMed Agema WR, Jukema JW, Zwinderman AH, Wall van der EE: A meta-analysis of the angiotensin-converting enzyme gene polymorphism and restenosis after percutaneous transluminal coronary revascularization: evidence for publication bias. Am Heart J. 2002, 144: 760-768.CrossRefPubMed

go back to reference Danser AH, Schalekamp MA, Bax WA, Brink van den AM, Saxena PR, Riegger GA, Schunkert H: Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation. 1995, 92: 1387-1388.CrossRefPubMed Danser AH, Schalekamp MA, Bax WA, Brink van den AM, Saxena PR, Riegger GA, Schunkert H: Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation. 1995, 92: 1387-1388.CrossRefPubMed

go back to reference Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction); American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Academic Emergency Medicine: ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation. 2007, 116: e148-e304. 10.1161/CIRCULATIONAHA.107.737312.CrossRefPubMed Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction); American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Academic Emergency Medicine: ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation. 2007, 116: e148-e304. 10.1161/CIRCULATIONAHA.107.737312.CrossRefPubMed

go back to reference Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, Hochman JS, Krumholz HM, Lamas GA, Mullany CJ, Pearle DL, Sloan MA, Smith SC, 2004 Writing Committee Members, Anbe DT, Kushner FG, Ornato JP, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW: 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation. 2008, 117: 296-329. 10.1161/CIRCULATIONAHA.107.188209.CrossRefPubMed Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, Hochman JS, Krumholz HM, Lamas GA, Mullany CJ, Pearle DL, Sloan MA, Smith SC, 2004 Writing Committee Members, Anbe DT, Kushner FG, Ornato JP, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW: 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation. 2008, 117: 296-329. 10.1161/CIRCULATIONAHA.107.188209.CrossRefPubMed

go back to reference Fraker TD, Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Fihn SD, Fraker TD, Gardin JM, O'Rourke RA, Williams SV, Smith SC, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW, American College of Cardiology; American Heart Association; American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group: 2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 Guidelines for the management of patients with chronic stable angina. Circulation. 2007, 116: 2762-2772. 10.1161/CIRCULATIONAHA.107.187930.CrossRefPubMed Fraker TD, Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Fihn SD, Fraker TD, Gardin JM, O'Rourke RA, Williams SV, Smith SC, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW, American College of Cardiology; American Heart Association; American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group: 2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 Guidelines for the management of patients with chronic stable angina. Circulation. 2007, 116: 2762-2772. 10.1161/CIRCULATIONAHA.107.187930.CrossRefPubMed

go back to reference Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts, Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL, Other experts who contributed to parts of the guidelines:, Walma E, Fitzgerald T, Cooney MT, Dudina A, European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG), Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Hellemans I, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A: European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J. 2007, 28: 2375-2414. 10.1093/eurheartj/ehm316.CrossRef Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts, Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL, Other experts who contributed to parts of the guidelines:, Walma E, Fitzgerald T, Cooney MT, Dudina A, European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG), Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Hellemans I, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A: European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J. 2007, 28: 2375-2414. 10.1093/eurheartj/ehm316.CrossRef

go back to reference Zintzaras E, Lau J: Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol. 2008, 61: 634-645. 10.1016/j.jclinepi.2007.12.011.CrossRefPubMed Zintzaras E, Lau J: Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol. 2008, 61: 634-645. 10.1016/j.jclinepi.2007.12.011.CrossRefPubMed

go back to reference Sterne JA, Egger M: Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001, 54: 1046-1055. 10.1016/S0895-4356(01)00377-8.CrossRefPubMed Sterne JA, Egger M: Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001, 54: 1046-1055. 10.1016/S0895-4356(01)00377-8.CrossRefPubMed

go back to reference Shanmugam V, Sell KW, Saha BK: Mistyping ACE heterozygotes. PCR Methods Appl. 1993, 3: 120-121.CrossRefPubMed Shanmugam V, Sell KW, Saha BK: Mistyping ACE heterozygotes. PCR Methods Appl. 1993, 3: 120-121.CrossRefPubMed

go back to reference Volzke H, Hertwig S, Rettig R, Motz W: The angiotensinogen gene 235T variant is associated with an increased risk of restenosis after percutaneous transluminal coronary angioplasty. Clin Sci (Lond). 2000, 99: 19-25.CrossRef Volzke H, Hertwig S, Rettig R, Motz W: The angiotensinogen gene 235T variant is associated with an increased risk of restenosis after percutaneous transluminal coronary angioplasty. Clin Sci (Lond). 2000, 99: 19-25.CrossRef

go back to reference Yoshida M, Iwai N, Ohmichi N, Izumi M, Nakamura Y, Kinoshita M: D allele of the angiotensin-converting enzyme gene is a risk factor for secondary cardiac events after myocardial infarction. Int J Cardiol. 1999, 70: 119-125. 10.1016/S0167-5273(99)00064-9.CrossRefPubMed Yoshida M, Iwai N, Ohmichi N, Izumi M, Nakamura Y, Kinoshita M: D allele of the angiotensin-converting enzyme gene is a risk factor for secondary cardiac events after myocardial infarction. Int J Cardiol. 1999, 70: 119-125. 10.1016/S0167-5273(99)00064-9.CrossRefPubMed

go back to reference Kasi JC, Zhang Y, Calvino R, Vazquez-Rodriguez JM, Castro-Beiras A, Jeffery S, Carter N: Angiotensin-converting enzyme insertion/deletion polymorphism and restenosis after coronary angioplasty in unstable angina pectoris. Am J Cardiol. 1996, 77: 875-877. 10.1016/S0002-9149(97)89187-4.CrossRefPubMed Kasi JC, Zhang Y, Calvino R, Vazquez-Rodriguez JM, Castro-Beiras A, Jeffery S, Carter N: Angiotensin-converting enzyme insertion/deletion polymorphism and restenosis after coronary angioplasty in unstable angina pectoris. Am J Cardiol. 1996, 77: 875-877. 10.1016/S0002-9149(97)89187-4.CrossRefPubMed

go back to reference Kamitani A, Rakugi H, Higaki J, Ohishi M, Shi SJ, Takami S, Nakata Y, Higashino Y, Fujii K, Mikami H: Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension. 1995, 25: 950-953.CrossRefPubMed Kamitani A, Rakugi H, Higaki J, Ohishi M, Shi SJ, Takami S, Nakata Y, Higashino Y, Fujii K, Mikami H: Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension. 1995, 25: 950-953.CrossRefPubMed

go back to reference Samani NJ, O'Toole L, Martin D, Rai H, Fletcher S, Lodwick D, Thompson JR, Morice AH, Channer K, Woods KL: Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction. J Am Coll Cardiol. 1996, 28: 338-344. 10.1016/0735-1097(96)00139-8.CrossRefPubMed Samani NJ, O'Toole L, Martin D, Rai H, Fletcher S, Lodwick D, Thompson JR, Morice AH, Channer K, Woods KL: Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction. J Am Coll Cardiol. 1996, 28: 338-344. 10.1016/0735-1097(96)00139-8.CrossRefPubMed

go back to reference van Bockxmeer FM, Mamotte CD, Gibbons FA, Burke V, Taylor RR: Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty. Circulation. 1995, 92: 2066-2071.CrossRefPubMed van Bockxmeer FM, Mamotte CD, Gibbons FA, Burke V, Taylor RR: Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty. Circulation. 1995, 92: 2066-2071.CrossRefPubMed

go back to reference Tsukada K, Ishimitsu T, Tsuchiya N, Horinaka S, Matsuoka H: Angiotensin-converting enzyme gene polymorphism and cardiovascular endocrine system in coronary angiography patients. Jpn Heart J. 1997, 38: 799-810.CrossRefPubMed Tsukada K, Ishimitsu T, Tsuchiya N, Horinaka S, Matsuoka H: Angiotensin-converting enzyme gene polymorphism and cardiovascular endocrine system in coronary angiography patients. Jpn Heart J. 1997, 38: 799-810.CrossRefPubMed

go back to reference Beohar N, Damaraju S, Prather A, Yu QT, Raizner A, Kleiman NS, Roberts R, Marian AJ: Angiotensin-I converting enzyme genotype DD is a risk factor for coronary artery disease. J Investig Med. 1995, 43: 275-280.PubMed Beohar N, Damaraju S, Prather A, Yu QT, Raizner A, Kleiman NS, Roberts R, Marian AJ: Angiotensin-I converting enzyme genotype DD is a risk factor for coronary artery disease. J Investig Med. 1995, 43: 275-280.PubMed

go back to reference Zee RY, Fernandez-Ortiz A, Macaya C, Pintor E, Lindpaintner K, Fernandez-Cruz A: Ace D/I polymorphism and incidence of post-PTCA restenosis: a prospective, angiography-based evaluation. Hypertension. 2001, 37: 851-855.CrossRefPubMed Zee RY, Fernandez-Ortiz A, Macaya C, Pintor E, Lindpaintner K, Fernandez-Cruz A: Ace D/I polymorphism and incidence of post-PTCA restenosis: a prospective, angiography-based evaluation. Hypertension. 2001, 37: 851-855.CrossRefPubMed

go back to reference Ohishi M, Fujii K, Minamino T, Higaki J, Kamitani A, Rakugi H, Zhao Y, Mikami H, Miki T, Ogihara T: A potent genetic risk factor for restenosis. Nat Genet. 1993, 5: 324-325. 10.1038/ng1293-324.CrossRefPubMed Ohishi M, Fujii K, Minamino T, Higaki J, Kamitani A, Rakugi H, Zhao Y, Mikami H, Miki T, Ogihara T: A potent genetic risk factor for restenosis. Nat Genet. 1993, 5: 324-325. 10.1038/ng1293-324.CrossRefPubMed

go back to reference Hertwig S, Volzke H, Robinson DM, Motz W, Rettig R: Angiotensinogen M235T gene polymorphism and recurrent restenosis after repeated percutaneous transluminal coronary angiography. Clin Sci (Lond). 2002, 103: 101-106.CrossRef Hertwig S, Volzke H, Robinson DM, Motz W, Rettig R: Angiotensinogen M235T gene polymorphism and recurrent restenosis after repeated percutaneous transluminal coronary angiography. Clin Sci (Lond). 2002, 103: 101-106.CrossRef

go back to reference Mulder HJ, van Geel PP, Schalij MJ, van Gilst WH, Zwinderman AH, Bruschke AV: DD ACE gene polymorphism is associated with increased coronary artery endothelial dysfunction: the PREFACE trial. Heart. 2003, 89: 557-558. 10.1136/heart.89.5.557.CrossRefPubMedPubMedCentral Mulder HJ, van Geel PP, Schalij MJ, van Gilst WH, Zwinderman AH, Bruschke AV: DD ACE gene polymorphism is associated with increased coronary artery endothelial dysfunction: the PREFACE trial. Heart. 2003, 89: 557-558. 10.1136/heart.89.5.557.CrossRefPubMedPubMedCentral

go back to reference Wijpkema JS, van Haelst PL, Monraats PS, Bruinenberg M, Zwinderman AH, Zijlstra F, Steege van der G, de Winter RJ, Doevendans PA, Waltenberger J, Jukema JW, Tio RA: Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1. Pharmacogenet Genomics. 2006, 16: 331-337. 10.1097/01.fpc.0000205001.07054.fa.CrossRefPubMed Wijpkema JS, van Haelst PL, Monraats PS, Bruinenberg M, Zwinderman AH, Zijlstra F, Steege van der G, de Winter RJ, Doevendans PA, Waltenberger J, Jukema JW, Tio RA: Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1. Pharmacogenet Genomics. 2006, 16: 331-337. 10.1097/01.fpc.0000205001.07054.fa.CrossRefPubMed

go back to reference Amant C, Bauters C, Bodart JC, Lablanche JM, Grollier G, Danchin N, Hamon M, Richard F, Helbecque N, McFadden EP, Amouyel P, Bertrand ME: D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation. 1997, 96: 56-60.CrossRefPubMed Amant C, Bauters C, Bodart JC, Lablanche JM, Grollier G, Danchin N, Hamon M, Richard F, Helbecque N, McFadden EP, Amouyel P, Bertrand ME: D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation. 1997, 96: 56-60.CrossRefPubMed

go back to reference Gomma AH, Elrayess MA, Knight CJ, Hawe E, Fox KM, Humphries SE: The endothelial nitric oxide synthase (Glu298Asp and -786T>C) gene polymorphisms are associated with coronary in-stent restenosis. Eur Heart J. 2002, 23: 1955-1962. 10.1053/euhj.2002.3400.CrossRefPubMed Gomma AH, Elrayess MA, Knight CJ, Hawe E, Fox KM, Humphries SE: The endothelial nitric oxide synthase (Glu298Asp and -786T>C) gene polymorphisms are associated with coronary in-stent restenosis. Eur Heart J. 2002, 23: 1955-1962. 10.1053/euhj.2002.3400.CrossRefPubMed

go back to reference Ryu SK, Cho EY, Park HY, Im EK, Jang YS, Shin GJ, Shim WH, Cho SY: Renin-angiotensin-aldosterone system (RAAS) gene polymorphism as a risk factor of coronary in-stent restenosis. Yonsei Med J. 2002, 43: 461-472.CrossRefPubMed Ryu SK, Cho EY, Park HY, Im EK, Jang YS, Shin GJ, Shim WH, Cho SY: Renin-angiotensin-aldosterone system (RAAS) gene polymorphism as a risk factor of coronary in-stent restenosis. Yonsei Med J. 2002, 43: 461-472.CrossRefPubMed

go back to reference Ribichini F, Ferrero V, Matullo G, Feola M, Vado A, Camilla T, Guarrera S, Carturan S, Vassanelli C, Uslenghi E, Piazza A: Association study of the I/D polymorphism and plasma angiotensin-converting enzyme (ACE) as risk factors for stent restenosis. Clin Sci (Lond). 2004, 107: 381-389.CrossRef Ribichini F, Ferrero V, Matullo G, Feola M, Vado A, Camilla T, Guarrera S, Carturan S, Vassanelli C, Uslenghi E, Piazza A: Association study of the I/D polymorphism and plasma angiotensin-converting enzyme (ACE) as risk factors for stent restenosis. Clin Sci (Lond). 2004, 107: 381-389.CrossRef

go back to reference Taniguchi I, Yamazaki T, Wagatsuma K, Kurusu T, Shimazu Y, Takikawa K, Yoshikawa M, Kageyama S, Mochizuki S: The DD genotype of angiotensin converting enzyme polymorphism is a risk factor for coronary artery disease and coronary stent restenosis in Japanese patients. Jpn Circ J. 2001, 65: 897-900. 10.1253/jcj.65.897.CrossRefPubMed Taniguchi I, Yamazaki T, Wagatsuma K, Kurusu T, Shimazu Y, Takikawa K, Yoshikawa M, Kageyama S, Mochizuki S: The DD genotype of angiotensin converting enzyme polymorphism is a risk factor for coronary artery disease and coronary stent restenosis in Japanese patients. Jpn Circ J. 2001, 65: 897-900. 10.1253/jcj.65.897.CrossRefPubMed

go back to reference Koch W, Kastrati A, Mehilli J, Bottiger C, von BN, Schomig A: Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement. Circulation. 2000, 102: 197-202.CrossRefPubMed Koch W, Kastrati A, Mehilli J, Bottiger C, von BN, Schomig A: Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement. Circulation. 2000, 102: 197-202.CrossRefPubMed

go back to reference Gurlek A, Gulec S, Karabulut H, Bokesoy I, Tutar E, Pamir G, Alpman A, Toydemir R, Aras O, Oral D: Relation between the insertion/deletion polymorphism of the angiotensin I converting enzyme gene and restenosis after coronary stenting. J Cardiovasc Risk. 2000, 7: 403-407.CrossRefPubMed Gurlek A, Gulec S, Karabulut H, Bokesoy I, Tutar E, Pamir G, Alpman A, Toydemir R, Aras O, Oral D: Relation between the insertion/deletion polymorphism of the angiotensin I converting enzyme gene and restenosis after coronary stenting. J Cardiovasc Risk. 2000, 7: 403-407.CrossRefPubMed

go back to reference Hamon M, Amant C, Bauters C, Richard F, Helbecque N, Passard F, McFadden EP, Lablanche JM, Bertrand ME, Amouyel P: Dual determination of angiotensin-converting enzyme and angiotensin-II type 1 receptor genotypes as predictors of restenosis after coronary angioplasty. Am J Cardiol. 1998, 81: 79-81. 10.1016/S0002-9149(97)00852-7.CrossRefPubMed Hamon M, Amant C, Bauters C, Richard F, Helbecque N, Passard F, McFadden EP, Lablanche JM, Bertrand ME, Amouyel P: Dual determination of angiotensin-converting enzyme and angiotensin-II type 1 receptor genotypes as predictors of restenosis after coronary angioplasty. Am J Cardiol. 1998, 81: 79-81. 10.1016/S0002-9149(97)00852-7.CrossRefPubMed

go back to reference Hamon M, Amant C, Bauters C, Lablanche JM, Bertrand M, Amouyel P: ACE polymorphism, a genetic predictor of occlusion after coronary angioplasty. Am J Cardiol. 1996, 78: 679-681. 10.1016/S0002-9149(96)00395-5.CrossRefPubMed Hamon M, Amant C, Bauters C, Lablanche JM, Bertrand M, Amouyel P: ACE polymorphism, a genetic predictor of occlusion after coronary angioplasty. Am J Cardiol. 1996, 78: 679-681. 10.1016/S0002-9149(96)00395-5.CrossRefPubMed

go back to reference Gross CM, Perrot A, Geier C, Posch MG, Hassfeld S, Kramer J, Schmidt S, Derer W, Dietz R, Ozcelik C: Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism. J Invasive Cardiol. 2007, 19: 261-264.PubMed Gross CM, Perrot A, Geier C, Posch MG, Hassfeld S, Kramer J, Schmidt S, Derer W, Dietz R, Ozcelik C: Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism. J Invasive Cardiol. 2007, 19: 261-264.PubMed

go back to reference Hamon M, Fradin S, Denizet A, Filippi-Codaccioni E, Grollier G, Morello R: Prospective evaluation of the effect of an angiotensin I converting enzyme gene polymorphism on the long term risk of major adverse cardiac events after percutaneous coronary intervention. Heart. 2003, 89: 321-325. 10.1136/heart.89.3.321.CrossRefPubMedPubMedCentral Hamon M, Fradin S, Denizet A, Filippi-Codaccioni E, Grollier G, Morello R: Prospective evaluation of the effect of an angiotensin I converting enzyme gene polymorphism on the long term risk of major adverse cardiac events after percutaneous coronary intervention. Heart. 2003, 89: 321-325. 10.1136/heart.89.3.321.CrossRefPubMedPubMedCentral

go back to reference Prisco D, Fatini C, Battaglini B, Gensini F, Fedi S, Falai M, Chioccioli M, Gori AM, Margheri M, Gensini GF: Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients. Int J Clin Lab Res. 2000, 30: 179-185. 10.1007/s005990070004.CrossRefPubMed Prisco D, Fatini C, Battaglini B, Gensini F, Fedi S, Falai M, Chioccioli M, Gori AM, Margheri M, Gensini GF: Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients. Int J Clin Lab Res. 2000, 30: 179-185. 10.1007/s005990070004.CrossRefPubMed

go back to reference Ribichini F, Wijns W, Ferrero V, Matullo G, Camilla T, Feola M, Guarrera S, Vado A, Piazza A, Uslenghi E: Effect of angiotensin-converting enzyme inhibition on restenosis after coronary stenting. Am J Cardiol. 2003, 91: 154-158. 10.1016/S0002-9149(02)03101-6.CrossRefPubMed Ribichini F, Wijns W, Ferrero V, Matullo G, Camilla T, Feola M, Guarrera S, Vado A, Piazza A, Uslenghi E: Effect of angiotensin-converting enzyme inhibition on restenosis after coronary stenting. Am J Cardiol. 2003, 91: 154-158. 10.1016/S0002-9149(02)03101-6.CrossRefPubMed

go back to reference Guneri S, Baris N, Aytekin D, Akdeniz B, Pekel N, Bozdemir V: The relationship between angiotensin converting enzyme gene polymorphism, coronary artery disease, and stent restenosis: the role of angiotensin converting enzyme inhibitors in stent restenosis in patients with diabetes mellitus. Int Heart J. 2005, 46: 889-897. 10.1536/ihj.46.889.CrossRefPubMed Guneri S, Baris N, Aytekin D, Akdeniz B, Pekel N, Bozdemir V: The relationship between angiotensin converting enzyme gene polymorphism, coronary artery disease, and stent restenosis: the role of angiotensin converting enzyme inhibitors in stent restenosis in patients with diabetes mellitus. Int Heart J. 2005, 46: 889-897. 10.1536/ihj.46.889.CrossRefPubMed

go back to reference Okamura A, Ohishi M, Rakugi H, Katsuya T, Yanagitani Y, Takiuchi S, Taniyama Y, Moriguchi K, Ito H, Higashino Y, Fujii K, Higaki J, Ogihara T: Pharmacogenetic analysis of the effect of angiotensin-converting enzyme inhibitor on restenosis after percutaneous transluminal coronary angioplasty. Angiology. 1999, 50: 811-822. 10.1177/000331979905001005.CrossRefPubMed Okamura A, Ohishi M, Rakugi H, Katsuya T, Yanagitani Y, Takiuchi S, Taniyama Y, Moriguchi K, Ito H, Higashino Y, Fujii K, Higaki J, Ogihara T: Pharmacogenetic analysis of the effect of angiotensin-converting enzyme inhibitor on restenosis after percutaneous transluminal coronary angioplasty. Angiology. 1999, 50: 811-822. 10.1177/000331979905001005.CrossRefPubMed

go back to reference Okumura K, Sone T, Kondo J, Tsuboi H, Mukawa H, Tsuzuki M, Imai H, Kamiya H, Mabuchi Y, Matsui H, Hayakawa T: Quinapril prevents restenosis after coronary stenting in patients with angiotensin-converting enzyme D allele. Circ J. 2002, 66: 311-316. 10.1253/circj.66.311.CrossRefPubMed Okumura K, Sone T, Kondo J, Tsuboi H, Mukawa H, Tsuzuki M, Imai H, Kamiya H, Mabuchi Y, Matsui H, Hayakawa T: Quinapril prevents restenosis after coronary stenting in patients with angiotensin-converting enzyme D allele. Circ J. 2002, 66: 311-316. 10.1253/circj.66.311.CrossRefPubMed

go back to reference Ferrari M, Mudra H, Grip L, Voudris V, Schachinger V, de Jaegere P, Rieber J, Hausmann D, Rothman M, Koschyk DH, Figulla HR, OPTICUS ACE Substudy: Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation. Cardiology. 2002, 97: 29-36. 10.1159/000047416.CrossRefPubMed Ferrari M, Mudra H, Grip L, Voudris V, Schachinger V, de Jaegere P, Rieber J, Hausmann D, Rothman M, Koschyk DH, Figulla HR, OPTICUS ACE Substudy: Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation. Cardiology. 2002, 97: 29-36. 10.1159/000047416.CrossRefPubMed

go back to reference Koch W, Mehilli J, von BN, Bottiger C, Schomig A, Kastrati A: Angiotensin I-converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene. J Am Coll Cardiol. 2003, 41: 1957-1961. 10.1016/S0735-1097(03)00406-6.CrossRefPubMed Koch W, Mehilli J, von BN, Bottiger C, Schomig A, Kastrati A: Angiotensin I-converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene. J Am Coll Cardiol. 2003, 41: 1957-1961. 10.1016/S0735-1097(03)00406-6.CrossRefPubMed

go back to reference Meurice T, Bauters C, Hermant X, Codron V, VanBelle E, Mc Fadden EP, Lablanche J, Bertrand ME, Amouyel P: Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial. Lancet. 2001, 357: 1321-1324. 10.1016/S0140-6736(00)04518-9.CrossRefPubMed Meurice T, Bauters C, Hermant X, Codron V, VanBelle E, Mc Fadden EP, Lablanche J, Bertrand ME, Amouyel P: Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial. Lancet. 2001, 357: 1321-1324. 10.1016/S0140-6736(00)04518-9.CrossRefPubMed

go back to reference Jorgensen E, Kelbaek H, Helqvist S, Jensen GV, Saunamaki K, Kastrup J, Havndrup O, Bundgaard H, Kyst Madsen J, Christiansen M, Andersen PS, Reiber JH: Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors. J Am Coll Cardiol. 2001, 38: 1434-1439. 10.1016/S0735-1097(01)01580-7.CrossRefPubMed Jorgensen E, Kelbaek H, Helqvist S, Jensen GV, Saunamaki K, Kastrup J, Havndrup O, Bundgaard H, Kyst Madsen J, Christiansen M, Andersen PS, Reiber JH: Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors. J Am Coll Cardiol. 2001, 38: 1434-1439. 10.1016/S0735-1097(01)01580-7.CrossRefPubMed

go back to reference Toyofyuku M, Imazu M, Sumii K, Yamamoto H, Hayashi Y, Hiyama K, Kohno N: Influence of angiotensinogen M253T gene polymorphism and an angiotensin converting enzyme inhibitor on restenosis after percutaneous coronary intervention. Atherosclerosis. 2002, 160: 339-344. 10.1016/S0021-9150(01)00592-5.CrossRefPubMed Toyofyuku M, Imazu M, Sumii K, Yamamoto H, Hayashi Y, Hiyama K, Kohno N: Influence of angiotensinogen M253T gene polymorphism and an angiotensin converting enzyme inhibitor on restenosis after percutaneous coronary intervention. Atherosclerosis. 2002, 160: 339-344. 10.1016/S0021-9150(01)00592-5.CrossRefPubMed

go back to reference Haberbosch W, Bohle RM, Franke FE, Danilov S, henc-Gelas F, Braun-Dullaeus R, Hölschermann H, Waas W, Tillmanns H, Gardemann A: The expression of angiotensin-I converting enzyme in human atherosclerotic plaques is not related to the deletion/insertion polymorphism but to the risk of restenosis after coronary interventions. Atherosclerosis. 1997, 130: 203-213. 10.1016/S0021-9150(96)06058-3.CrossRefPubMed Haberbosch W, Bohle RM, Franke FE, Danilov S, henc-Gelas F, Braun-Dullaeus R, Hölschermann H, Waas W, Tillmanns H, Gardemann A: The expression of angiotensin-I converting enzyme in human atherosclerotic plaques is not related to the deletion/insertion polymorphism but to the risk of restenosis after coronary interventions. Atherosclerosis. 1997, 130: 203-213. 10.1016/S0021-9150(96)06058-3.CrossRefPubMed

go back to reference Canosi U, Angelica Merlini P, Bernardi F, Repetto A, Bramucci E, Ferrario M, Angoli L, Gnecchi M, Ferraresi P, Marchetti G, Tavazzi L, Ardissino D: Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation. Thromb Haemost. 2004, 91: 795-800.PubMed Canosi U, Angelica Merlini P, Bernardi F, Repetto A, Bramucci E, Ferrario M, Angoli L, Gnecchi M, Ferraresi P, Marchetti G, Tavazzi L, Ardissino D: Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation. Thromb Haemost. 2004, 91: 795-800.PubMed

go back to reference Dayi SU, Tartan Z, Terzi S, Kasikcioglu H, Uyarel H, Orhan G, Alper AT, Ciloglu F, Cam N: Influence of angiotensin converting enzyme insertion/deletion polymorphism on long-term total graft occlusion after coronary artery bypass surgery. Heart Surg Forum. 2005, 8: E373-E377. 10.1532/HSF98.20051113.CrossRefPubMed Dayi SU, Tartan Z, Terzi S, Kasikcioglu H, Uyarel H, Orhan G, Alper AT, Ciloglu F, Cam N: Influence of angiotensin converting enzyme insertion/deletion polymorphism on long-term total graft occlusion after coronary artery bypass surgery. Heart Surg Forum. 2005, 8: E373-E377. 10.1532/HSF98.20051113.CrossRefPubMed

go back to reference Ortlepp JR, Janssens U, Bleckmann F, Lauscher J, Merkelbach-Bruse S, Hanrath P, Hoffmann R: A chymase gene variant is associated with atherosclerosis in venous coronary artery bypass grafts. Coron Artery Dis. 2001, 12: 493-497. 10.1097/00019501-200109000-00008.CrossRefPubMed Ortlepp JR, Janssens U, Bleckmann F, Lauscher J, Merkelbach-Bruse S, Hanrath P, Hoffmann R: A chymase gene variant is associated with atherosclerosis in venous coronary artery bypass grafts. Coron Artery Dis. 2001, 12: 493-497. 10.1097/00019501-200109000-00008.CrossRefPubMed

go back to reference Volzke H, Engel J, Kleine V, Schwahn C, Dahm JB, Eckel L, Rettig R: Angiotensin I-converting enzyme insertion/deletion polymorphism and cardiac mortality and morbidity after coronary artery bypass graft surgery. Chest. 2002, 122: 31-36. 10.1378/chest.122.1.31.CrossRefPubMed Volzke H, Engel J, Kleine V, Schwahn C, Dahm JB, Eckel L, Rettig R: Angiotensin I-converting enzyme insertion/deletion polymorphism and cardiac mortality and morbidity after coronary artery bypass graft surgery. Chest. 2002, 122: 31-36. 10.1378/chest.122.1.31.CrossRefPubMed

go back to reference Voors AA, van Geel PP, Oosterga M, Buikema H, van Veldhuisen DJ, van Gilst WH: Vascular effects of quinapril completely depend on ACE insertion/deletion polymorphism. J Renin Angiotensin Aldosterone Syst. 2004, 5: 130-134. 10.3317/jraas.2004.029.CrossRefPubMed Voors AA, van Geel PP, Oosterga M, Buikema H, van Veldhuisen DJ, van Gilst WH: Vascular effects of quinapril completely depend on ACE insertion/deletion polymorphism. J Renin Angiotensin Aldosterone Syst. 2004, 5: 130-134. 10.3317/jraas.2004.029.CrossRefPubMed

go back to reference Arnett DK, Davis BR, Ford CE, Boerwinkle E, Leiendecker-Foster C, Miller MB, Black H, Eckfeldt JH: Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment: the Genetics of Hypertension-Associated Treatment (GenHAT) study. Circulation. 2005, 111: 3374-3383. 10.1161/CIRCULATIONAHA.104.504639.CrossRefPubMed Arnett DK, Davis BR, Ford CE, Boerwinkle E, Leiendecker-Foster C, Miller MB, Black H, Eckfeldt JH: Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment: the Genetics of Hypertension-Associated Treatment (GenHAT) study. Circulation. 2005, 111: 3374-3383. 10.1161/CIRCULATIONAHA.104.504639.CrossRefPubMed

go back to reference Harrap SB, Tzourio C, Cambien F, Poirier O, Raoux S, Chalmers J, Chapman N, Colman S, Leguennec S, MacMahon S, Neal B, Ohkubo T, Woodward M, PROGRESS Collaborative Group: The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition. Hypertension. 2003, 42: 297-303. 10.1161/01.HYP.0000088322.85804.96.CrossRefPubMed Harrap SB, Tzourio C, Cambien F, Poirier O, Raoux S, Chalmers J, Chapman N, Colman S, Leguennec S, MacMahon S, Neal B, Ohkubo T, Woodward M, PROGRESS Collaborative Group: The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition. Hypertension. 2003, 42: 297-303. 10.1161/01.HYP.0000088322.85804.96.CrossRefPubMed

go back to reference Marciante KD, Bis JC, Rieder MJ, Reiner AP, Lumley T, Monks SA, Kooperberg C, Carlson C, Heckbert SR, Psaty BM: Renin-angiotensin system haplotypes and the risk of myocardial infarction and stroke in pharmacologically treated hypertensive patients. Am J Epidemiol. 2007, 166: 19-27. 10.1093/aje/kwm059.CrossRefPubMed Marciante KD, Bis JC, Rieder MJ, Reiner AP, Lumley T, Monks SA, Kooperberg C, Carlson C, Heckbert SR, Psaty BM: Renin-angiotensin system haplotypes and the risk of myocardial infarction and stroke in pharmacologically treated hypertensive patients. Am J Epidemiol. 2007, 166: 19-27. 10.1093/aje/kwm059.CrossRefPubMed

go back to reference Pinto YM, van Gilst WH, Kingma JH, Schunkert H: Deletion-type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilation after anterior myocardial infarction. Captopril and Thrombolysis Study Investigators. J Am Coll Cardiol. 1995, 25: 1622-1626. 10.1016/0735-1097(95)00090-Q.CrossRefPubMed Pinto YM, van Gilst WH, Kingma JH, Schunkert H: Deletion-type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilation after anterior myocardial infarction. Captopril and Thrombolysis Study Investigators. J Am Coll Cardiol. 1995, 25: 1622-1626. 10.1016/0735-1097(95)00090-Q.CrossRefPubMed

go back to reference Zee RY, Solomon SD, Ajani UA, Pfeffer MA, Lindpaintner K: A prospective evaluation of the angiotensin-converting enzyme D/I polymorphism and left ventricular remodeling in the 'Healing and Early Afterload Reducing Therapy' study. Clin Genet. 2002, 61: 21-25. 10.1034/j.1399-0004.2002.610104.x.CrossRefPubMed Zee RY, Solomon SD, Ajani UA, Pfeffer MA, Lindpaintner K: A prospective evaluation of the angiotensin-converting enzyme D/I polymorphism and left ventricular remodeling in the 'Healing and Early Afterload Reducing Therapy' study. Clin Genet. 2002, 61: 21-25. 10.1034/j.1399-0004.2002.610104.x.CrossRefPubMed

go back to reference Kennon S, Barakat K, Hitman GA, Price CP, Mills PG, Ranjadayalan K, Cooper J, Clark H, Timmis AD: Angiotensin-converting enzyme inhibition is associated with reduced troponin release in non-ST-elevation acute coronary syndromes. J Am Coll Cardiol. 2001, 38: 724-728. 10.1016/S0735-1097(01)01426-7.CrossRefPubMed Kennon S, Barakat K, Hitman GA, Price CP, Mills PG, Ranjadayalan K, Cooper J, Clark H, Timmis AD: Angiotensin-converting enzyme inhibition is associated with reduced troponin release in non-ST-elevation acute coronary syndromes. J Am Coll Cardiol. 2001, 38: 724-728. 10.1016/S0735-1097(01)01426-7.CrossRefPubMed

go back to reference Prasad A, Narayanan S, Husain S, Padder F, Waclawiw M, Epstein N, Quyyumi AA: Insertion-deletion polymorphism of the ACE gene modulates reversibility of endothelial dysfunction with ACE inhibition. Circulation. 2000, 102: 35-41.CrossRefPubMed Prasad A, Narayanan S, Husain S, Padder F, Waclawiw M, Epstein N, Quyyumi AA: Insertion-deletion polymorphism of the ACE gene modulates reversibility of endothelial dysfunction with ACE inhibition. Circulation. 2000, 102: 35-41.CrossRefPubMed

go back to reference Trevelyan J, Needham EW, Morris A, Mattu RK: Comparison of the effect of enalapril and losartan in conjunction with surgical coronary revascularisation versus revascularisation alone on systemic endothelial function. Heart. 2005, 91: 1053-1057. 10.1136/hrt.2004.036897.CrossRefPubMedPubMedCentral Trevelyan J, Needham EW, Morris A, Mattu RK: Comparison of the effect of enalapril and losartan in conjunction with surgical coronary revascularisation versus revascularisation alone on systemic endothelial function. Heart. 2005, 91: 1053-1057. 10.1136/hrt.2004.036897.CrossRefPubMedPubMedCentral

go back to reference Pedersen OD, Gram J, Jeunemaitre X, Billaud E, Jespersen J: Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction. Coron Artery Dis. 1997, 8: 283-291. 10.1097/00019501-199705000-00005.CrossRefPubMed Pedersen OD, Gram J, Jeunemaitre X, Billaud E, Jespersen J: Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction. Coron Artery Dis. 1997, 8: 283-291. 10.1097/00019501-199705000-00005.CrossRefPubMed

go back to reference Jeron A, Hengstenberg C, Engel S, Lowel H, Riegger GA, Schunkert H, Holmer S: The D-allele of the ACE polymorphism is related to increased QT dispersion in 609 patients after myocardial infarction. Eur Heart J. 2001, 22: 663-668. 10.1053/euhj.2000.2297.CrossRefPubMed Jeron A, Hengstenberg C, Engel S, Lowel H, Riegger GA, Schunkert H, Holmer S: The D-allele of the ACE polymorphism is related to increased QT dispersion in 609 patients after myocardial infarction. Eur Heart J. 2001, 22: 663-668. 10.1053/euhj.2000.2297.CrossRefPubMed

go back to reference Steeds RP, Fletcher J, Parry H, Chowdhary S, Channer KS, West J, Townend JN: The angiotensin-converting enzyme gene I/D polymorphism and heart rate variability following acute myocardial infarction. Clin Auton Res. 2002, 12: 66-71. 10.1007/s102860200022.CrossRefPubMed Steeds RP, Fletcher J, Parry H, Chowdhary S, Channer KS, West J, Townend JN: The angiotensin-converting enzyme gene I/D polymorphism and heart rate variability following acute myocardial infarction. Clin Auton Res. 2002, 12: 66-71. 10.1007/s102860200022.CrossRefPubMed

go back to reference Zee Maitland-van der AH, Boerwinkle E, Arnett DK, Davis BR, Leiendecker-Foster C, Miller MB, Klungel OH, Ford CE, Eckfeldt JH: Absence of an interaction between the angiotensin-converting enzyme insertion-deletion polymorphism and pravastatin on cardiovascular disease in high-risk hypertensive patients: the Genetics of Hypertension-Associated Treatment (GenHAT) study. Am Heart J. 2007, 153: 54-58. 10.1016/j.ahj.2006.10.019.CrossRef Zee Maitland-van der AH, Boerwinkle E, Arnett DK, Davis BR, Leiendecker-Foster C, Miller MB, Klungel OH, Ford CE, Eckfeldt JH: Absence of an interaction between the angiotensin-converting enzyme insertion-deletion polymorphism and pravastatin on cardiovascular disease in high-risk hypertensive patients: the Genetics of Hypertension-Associated Treatment (GenHAT) study. Am Heart J. 2007, 153: 54-58. 10.1016/j.ahj.2006.10.019.CrossRef

go back to reference Zee Maitland-van der AH, Stricker BH, Klungel OH, Kastelein JJ, Hofman A, Witteman JC, Leufkens HG, Duijn CM, Boer AdA: Effectiveness of HMG-CoA reductase inhibitors is modified by the ACE insertion deletion polymorphism. Atherosclerosis. 2004, 175: 377-379. 10.1016/j.atherosclerosis.2004.01.042.CrossRef Zee Maitland-van der AH, Stricker BH, Klungel OH, Kastelein JJ, Hofman A, Witteman JC, Leufkens HG, Duijn CM, Boer AdA: Effectiveness of HMG-CoA reductase inhibitors is modified by the ACE insertion deletion polymorphism. Atherosclerosis. 2004, 175: 377-379. 10.1016/j.atherosclerosis.2004.01.042.CrossRef

go back to reference Bray PF, Cannon CP, Goldschmidt-Clermont P, Moye LA, Pfeffer MA, Sacks FM, Braunwald E: The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction. Am J Cardiol. 2001, 88: 347-352. 10.1016/S0002-9149(01)01677-0.CrossRefPubMed Bray PF, Cannon CP, Goldschmidt-Clermont P, Moye LA, Pfeffer MA, Sacks FM, Braunwald E: The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction. Am J Cardiol. 2001, 88: 347-352. 10.1016/S0002-9149(01)01677-0.CrossRefPubMed

go back to reference Marian AJ, Safavi F, Ferlic L, Dunn JK, Gotto AM, Ballantyne CM: Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin: the lipoprotein and coronary atherosclerosis study. J Am Coll Cardiol. 2000, 35: 89-95. 10.1016/S0735-1097(99)00535-5.CrossRefPubMed Marian AJ, Safavi F, Ferlic L, Dunn JK, Gotto AM, Ballantyne CM: Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin: the lipoprotein and coronary atherosclerosis study. J Am Coll Cardiol. 2000, 35: 89-95. 10.1016/S0735-1097(99)00535-5.CrossRefPubMed

go back to reference Talmud PJ, Watts GF, McBride S, Mandalia S, Brunt JN, Coltart DJ, Lewis B, Humphries SE: Angiotensin converting enzyme gene polymorphism and the course of angiographically defined coronary artery disease. Atherosclerosis. 1995, 114: 133-135. 10.1016/0021-9150(94)05467-W.CrossRefPubMed Talmud PJ, Watts GF, McBride S, Mandalia S, Brunt JN, Coltart DJ, Lewis B, Humphries SE: Angiotensin converting enzyme gene polymorphism and the course of angiographically defined coronary artery disease. Atherosclerosis. 1995, 114: 133-135. 10.1016/0021-9150(94)05467-W.CrossRefPubMed

go back to reference Defoor J, Vanhees L, Martens K, Matthijs G, Van VA, Zielinska D, Schepers D, Vlietinck R, Fagard R: The CAREGENE study: ACE gene I/D polymorphism and effect of physical training on aerobic power in coronary artery disease. Heart. 2006, 92: 527-528. 10.1136/hrt.2004.054312.CrossRefPubMedPubMedCentral Defoor J, Vanhees L, Martens K, Matthijs G, Van VA, Zielinska D, Schepers D, Vlietinck R, Fagard R: The CAREGENE study: ACE gene I/D polymorphism and effect of physical training on aerobic power in coronary artery disease. Heart. 2006, 92: 527-528. 10.1136/hrt.2004.054312.CrossRefPubMedPubMedCentral

go back to reference Iwanaga Y, Nishi I, Ono K, Takagi S, Tsutsumi Y, Ozaki M, Noguchi T, Takaki H, Iwai N, Nonogi H, Goto Y: Angiotensin-converting enzyme genotype is not associated with exercise capacity or the training effect of cardiac rehabilitation in patients after acute myocardial infarction. Circ J. 2005, 69: 1315-1319. 10.1253/circj.69.1315.CrossRefPubMed Iwanaga Y, Nishi I, Ono K, Takagi S, Tsutsumi Y, Ozaki M, Noguchi T, Takaki H, Iwai N, Nonogi H, Goto Y: Angiotensin-converting enzyme genotype is not associated with exercise capacity or the training effect of cardiac rehabilitation in patients after acute myocardial infarction. Circ J. 2005, 69: 1315-1319. 10.1253/circj.69.1315.CrossRefPubMed

go back to reference Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, Menichelli M, Sabaté M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schömig A: Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007, 356: 1030-1039. 10.1056/NEJMoa067484.CrossRefPubMed Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, Menichelli M, Sabaté M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schömig A: Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007, 356: 1030-1039. 10.1056/NEJMoa067484.CrossRefPubMed

go back to reference Betriu A, Masotti M, Serra A, Alonso J, Fernandez-Aviles F, Gimeno F, Colman T, Zueco J, Delcan JL, García E, Calabuig J: Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): a four-year follow-up. J Am Coll Cardiol. 1999, 34: 1498-1506. 10.1016/S0735-1097(99)00366-6.CrossRefPubMed Betriu A, Masotti M, Serra A, Alonso J, Fernandez-Aviles F, Gimeno F, Colman T, Zueco J, Delcan JL, García E, Calabuig J: Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): a four-year follow-up. J Am Coll Cardiol. 1999, 34: 1498-1506. 10.1016/S0735-1097(99)00366-6.CrossRefPubMed

go back to reference Keavney B: Outcome following percutaneous coronary intervention: not, so far, in our genes. Heart. 2003, 89: 247-248. 10.1136/heart.89.3.247.CrossRefPubMedPubMedCentral Keavney B: Outcome following percutaneous coronary intervention: not, so far, in our genes. Heart. 2003, 89: 247-248. 10.1136/heart.89.3.247.CrossRefPubMedPubMedCentral

go back to reference Welt FG, Rogers C: Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol. 2002, 22: 1769-1776. 10.1161/01.ATV.0000037100.44766.5B.CrossRefPubMed Welt FG, Rogers C: Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol. 2002, 22: 1769-1776. 10.1161/01.ATV.0000037100.44766.5B.CrossRefPubMed

go back to reference McKenzie CA, Abecasis GR, Keavney B, Forrester T, Ratcliffe PJ, Julier C, Connell JM, Bennett F, McFarlane-Anderson N, Lathrop GM, Cardon LR: Trans-ethnic fine mapping of a quantitative trait locus for circulating angiotensin I-converting enzyme (ACE). Hum Mol Genet. 2001, 10: 1077-1084. 10.1093/hmg/10.10.1077.CrossRefPubMed McKenzie CA, Abecasis GR, Keavney B, Forrester T, Ratcliffe PJ, Julier C, Connell JM, Bennett F, McFarlane-Anderson N, Lathrop GM, Cardon LR: Trans-ethnic fine mapping of a quantitative trait locus for circulating angiotensin I-converting enzyme (ACE). Hum Mol Genet. 2001, 10: 1077-1084. 10.1093/hmg/10.10.1077.CrossRefPubMed

go back to reference Dhawan J, Bray CL: Are Asian coronary arteries smaller than Caucasian? A study on angiographic coronary artery size estimation during life. Int J Cardiol. 1995, 49: 267-269. 10.1016/0167-5273(95)02315-N.CrossRefPubMed Dhawan J, Bray CL: Are Asian coronary arteries smaller than Caucasian? A study on angiographic coronary artery size estimation during life. Int J Cardiol. 1995, 49: 267-269. 10.1016/0167-5273(95)02315-N.CrossRefPubMed

go back to reference Balk EM, Bonis PA, Moskowitz H, Schmid CH, Ioannidis JP, Wang C, Lau J: Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. JAMA. 2002, 287: 2973-2982. 10.1001/jama.287.22.2973.CrossRefPubMed Balk EM, Bonis PA, Moskowitz H, Schmid CH, Ioannidis JP, Wang C, Lau J: Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. JAMA. 2002, 287: 2973-2982. 10.1001/jama.287.22.2973.CrossRefPubMed

go back to reference Bavry AA, Bhatt DL: Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis. Lancet. 2008, 371: 2134-2143. 10.1016/S0140-6736(08)60922-8.CrossRefPubMed Bavry AA, Bhatt DL: Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis. Lancet. 2008, 371: 2134-2143. 10.1016/S0140-6736(08)60922-8.CrossRefPubMed

go back to reference Zhu X, Bouzekri N, Southam L, Cooper RS, Adeyemo A, McKenzie CA, Luke A, Chen G, Elston RC, Ward R: Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet. 2001, 68: 1139-1148. 10.1086/320104.CrossRefPubMedPubMedCentral Zhu X, Bouzekri N, Southam L, Cooper RS, Adeyemo A, McKenzie CA, Luke A, Chen G, Elston RC, Ward R: Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet. 2001, 68: 1139-1148. 10.1086/320104.CrossRefPubMedPubMedCentral

go back to reference Cordell HJ: Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. Hum Mol Genet. 2002, 11: 2463-2468. 10.1093/hmg/11.20.2463.CrossRefPubMed Cordell HJ: Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. Hum Mol Genet. 2002, 11: 2463-2468. 10.1093/hmg/11.20.2463.CrossRefPubMed

go back to reference SEARCH Collaborative Group, Link E, Parish S, Armitage J, Bowman L, Heath S, Matsuda F, Gut I, Lathrop M, Collins R: SLCO1B1 variants and statin-induced myopathy – a genomewide study. N Engl J Med. 2008, 359: 789-799. 10.1056/NEJMoa0801936.CrossRef SEARCH Collaborative Group, Link E, Parish S, Armitage J, Bowman L, Heath S, Matsuda F, Gut I, Lathrop M, Collins R: SLCO1B1 variants and statin-induced myopathy – a genomewide study. N Engl J Med. 2008, 359: 789-799. 10.1056/NEJMoa0801936.CrossRef

go back to reference Veenstra DL, Higashi MK, Phillips KA: Assessing the cost-effectiveness of pharmacogenomics. AAPS PharmSci. 2000, 2: E29-10.1208/ps020329.CrossRefPubMed Veenstra DL, Higashi MK, Phillips KA: Assessing the cost-effectiveness of pharmacogenomics. AAPS PharmSci. 2000, 2: E29-10.1208/ps020329.CrossRefPubMed

go back to reference Zee Maitland-van der AH, Klungel OH, Stricker BH, Veenstra DL, Kastelein JJ, Hofman A, Witteman JC, Leufkens HG, van Duijn CM, de Boer A: Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting beta-hydroxy-beta-methylglutaryl coenzyme A reductase inhibitor therapy in men. Pharmacogenetics. 2004, 14: 53-60. 10.1097/00008571-200401000-00006.CrossRef Zee Maitland-van der AH, Klungel OH, Stricker BH, Veenstra DL, Kastelein JJ, Hofman A, Witteman JC, Leufkens HG, van Duijn CM, de Boer A: Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting beta-hydroxy-beta-methylglutaryl coenzyme A reductase inhibitor therapy in men. Pharmacogenetics. 2004, 14: 53-60. 10.1097/00008571-200401000-00006.CrossRef